The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Modification of Sample Size in Group Sequential Clinical Trials
Abstract
Summary. In group sequential clinical trials, sample size reestimation can be a complicated issue when it allows for change of sample size to be influenced by an observed sample path. Our simulation studies show that increasing sample size based on an interim estimate of the treatment difference can substantially inflate the probability of type I error in most practical situations. A new group sequential test procedure is developed by modifying the weights used in the traditional repeated significance two‐sample mean test. The new test has the type I error probability preserved at the target level and can provide a substantial gain in power with the increase of sample size. Generalization of the new procedure is discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Discrete sequential boundaries for clinical trials
GORDON LAN, K. K., & DEMETS, D. L. (1983) · Biometrika · doi:10.1093/biomet/70.3.659 · Cited by 2,310
Group sequential methods in the design and analysis of clinical trials
POCOCK, S. J. (1977) · Biometrika · doi:10.1093/biomet/64.2.191 · Cited by 1,831
Research works printed but not linked: 12
- 10.1002/sim.4780110107 · DOI
- 10.1080/03610929208830947 · DOI · Paper page
- 10.2307/2336502 · DOI · Paper page
- Lan K. K. G.andTrost D. C.(1997).Estimation of parameters and sample size reestimation.Proceedings of Biopharmaceutical Section American Statistical Association.
- 10.2307/2531870 · DOI · Paper page
- Lan K. K. G., 1982, Stochastically curtailed tests in long‐term clinical trials, Communications in Statistics, 1, 207
- 10.2307/2530245 · DOI · Paper page
- 10.2307/2530298 · DOI · Paper page
- 10.2307/2533262 · DOI · Paper page
- Shih W. J., 1992, Biopharmaceutical Sequential Statistical Applications, 285
- 10.1177/009286159302700318 · DOI
- 10.1002/sim.4780090113 · DOI · Paper page
Cited by
Combination of Isosorbide Dinitrate and Hydralazine in Blacks with Heart Failure
Taylor, A. L., Ziesche, S., Yancy, C., Carson, P., D'Agostino, R., Ferdinand, K., Taylor, M., Adams, K., Sabolinski, M., Worcel, M., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa042934 · Cited by 1,773
Bretz, F., Hothorn, T., & Westfall, P. (2016) · doi:10.1201/9781420010909 · Cited by 1,233
Adjuvant Sunitinib in High-Risk Renal-Cell Carcinoma after Nephrectomy
Ravaud, A., Motzer, R. J., Pandha, H. S., George, D. J., Pantuck, A. J., Patel, A., Chang, Y.-H., Escudier, B., Donskov, F., Magheli, A., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1611406 · Cited by 782
Vedolizumab versus Adalimumab for Moderate-to-Severe Ulcerative Colitis
Sands, B. E., Peyrin-Biroulet, L., Loftus, E. V., Danese, S., Colombel, J.-F., Törüner, M., Jonaitis, L., Abhyankar, B., Chen, J., Rogers, R., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1905725 · Cited by 754
Fedgchin, M., Trivedi, M., Daly, E. J., Melkote, R., Lane, R., Lim, P., Vitagliano, D., Blier, P., Fava, M., Liebowitz, M., et al. (2019) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyz039 · Cited by 606
Metadata
- Authors
- Cui, L., Hung, H. M. J., & Wang, S.
- Venue
- Biometrics
- Publisher
- Oxford University Press (OUP)
- Published
- 1999-09
- Volume
- 55
- Issue
- 3
- Pages
- 853-857
- ISSN
- 0006-341X (ISSN-L)
- 1541-0420
- OpenAlex
- W2088238660
- Cited by
- 574
- References
- 2
- FWCI
- 10.20
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Modification of Sample Size in Group Sequential Clinical Trials. https://app.cochat.ai/papers/10.1111/j.0006-341x.1999.00853.x
- The paper
- Cui, L., Hung, H. M. J., & Wang, S. (1999). Modification of Sample Size in Group Sequential Clinical Trials. Biometrics. https://doi.org/10.1111/j.0006-341x.1999.00853.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.